OREANDA-NEWS. February 11, 2014. ABLV Private Equity Fund 2010, KS which is a part of ABLV Group, has increased its shareholding in the leading Latvian pharmaceutical company AS Grindeks to 22.66%. In addition to AS Grindeks shares previously owned, ABLV Private Equity Fund 2010, KS has purchased 1 081 593 shares from funds managed by fund manager East Capital.

The additional share purchase was made to support AS Grindeks and its management in realising the company’s significant potential for development of new products and increasing sales in export markets.

ABLV Private Equity Fund 2010, KS is a private equity fund with 100% local capital, and it invests in leading and promising companies, becoming a reliable long-term financial partner. The fund also holds capital shares in such companies as SIA Depo DIY, SIA Orto klinika, and SIA Vainode Agro Holding.